Corvus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies to transform the lives of patients with cancer. They specialize in targeting the immune checkpoints that allow cancer to evade detection and attack by the immune system. With a diverse portfolio of potential drug candidates, Corvus is dedicated to advancing the field of cancer treatment and improving patient outcomes.
Notification